2027년 1월 28일
FDA PDUFA target action date for ARIKAYCE (amikacin liposome inhalation suspension), a NDA from Insmed. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA 결정 날짜 캘린더